Neuberg Diagnostics Launches Wellness Hub in Chennai

Neuberg Diagnostics Launches Wellness Hub in Chennai

India Pharma Outlook Team | Tuesday, 07 October 2025

 Neuberg

Neuberg Diagnostics, has added a Wellness Centre and Processing Lab to its list of facilities in Chennai. This new Wellness Centre in Abhiramapuram was inaugurated by Dr. Sengottuvelu G, Senior Consultant and Interventional Cardiologist at Apollo Hospitals, in the presence of Dr. GSK Velu, Chairman and Managing Director of Neuberg Diagnostics.

Being situated in the middle of one of the most comfortable and attractive areas of Chennai the Abhiramapuram Wellness Centre is an excellent example of Neuberg’s commitment to bringing preventive and personalised healthcare within the reach of the common man.

The centre is expected to become the hub of this 360-degree healthcare programme which will have services such as blood collection, rapid home collection, ECG, X-ray, ultrasound, eye check-ups, lifestyle management programmes, and doctor consultations—all under one roof.

Moreover, the facility equipped with a high-capacity processing lab, enables the handling of over 1,000 samples per day, which makes it possible to give patients as well as corporate wellness clients, faster and more accurate results.

Also Read: Biocon, Carnegie Get USFDA Nod for Rifaximin IBS-D Tablets

The 150th Neuberg touchpoint in Chennai, followed by this milestone, is a way for the company to emphasize its mission of bringing superb diagnostics closer to where people are. “Our goal is to make quality healthcare accessible and proactive,” said Dr. GSK Velu. “This centre marks a place where people can be empowered to adopt a healthy lifestyle.”

Geographically, Neuberg Diagnostics has its main office in Chennai, but the company is present in several countries such as India, the UAE, South Africa, and the USA, and has more than 200 CAP- and NABL-accredited laboratories all over the globe, which makes it one of the fastest-growing diagnostic networks in the world.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.